Skip to main navigation Skip to search Skip to main content

Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease.

  • Steven I. Park
  • , Jaideep Shenoi
  • , John M. Pagel
  • , Donald K. Hamlin
  • , Nural Orgun
  • , Aimee L. Kenoyer
  • , Shani M. Wilbur
  • , Amanda Axtman
  • , D. Scott Wilbur
  • , Yukang Lin
  • , Darrell R. Fisher
  • , Ajay K. Gopal
  • , Damian J. Green
  • , Oliver W. Press

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalBlood
    Volume114
    StatePublished - Nov 20 2009

    Disciplines

    • Medicine and Health Sciences
    • Immunology and Infectious Disease

    Cite this